David M Reese Amgen Inc (AMGN) insider trading activity

David M Reese is EVP & Chief Technology Officer of AMGEN INC. Currently has a direct ownership of 61,889 shares of AMGN, which is worth approximately $18.2 Million. The most recent transaction as insider was on Mar 19, 2021, when has been sold 1,401 shares (Common Stock) at a price of $244.42 per share, resulting in proceeds of $342,432. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61.9K

0% 3M change

14.37% 12M change

Total Value Held $18.2 Million

DAVID M REESE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 19 2021	SELL Payment of exercise price or tax liability	$342,432 $244.42 p/Share	1,401 Reduced 3.19%	42,494 Common Stock
Mar 02 2021	BUY Grant, award, or other acquisition	-	2,803 Added 6.03%	43,715 Common Stock
Feb 16 2021	SELL Payment of exercise price or tax liability	$272,080 $237.21 p/Share	1,147 Reduced 2.73%	40,912 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	$125,787 $54.69 p/Share	2,300 Added 5.18%	42,059 Common Stock
Nov 02 2020	SELL Payment of exercise price or tax liability	$460,998 $216.94 p/Share	2,125 Reduced 5.09%	39,619 Common Stock
May 05 2020	BUY Grant, award, or other acquisition	-	3,469 Added 7.73%	41,408 Common Stock
May 03 2020	SELL Payment of exercise price or tax liability	$42,731 $230.98 p/Share	185 Reduced 0.49%	37,939 Common Stock
May 01 2020	SELL Payment of exercise price or tax liability	$250,224 $239.22 p/Share	1,046 Reduced 2.67%	38,124 Common Stock
Apr 27 2020	SELL Payment of exercise price or tax liability	$39,695 $236.28 p/Share	168 Reduced 0.43%	39,170 Common Stock
Mar 20 2020	SELL Payment of exercise price or tax liability	$368,700 $198.76 p/Share	1,855 Reduced 4.5%	39,338 Common Stock
Mar 09 2020	SELL Exercise of conversion of derivative security	$86,476 $58.43 p/Share	1,480 Reduced 3.42%	41,765 Common Stock
Mar 09 2020	SELL Payment of exercise price or tax liability	$164,307 $210.65 p/Share	780 Reduced 1.87%	40,985 Common Stock
Mar 03 2020	BUY Grant, award, or other acquisition	-	3,711 Added 8.43%	40,285 Common Stock
May 03 2019	SELL Payment of exercise price or tax liability	$30,711 $176.5 p/Share	174 Reduced 0.55%	31,564 Common Stock
May 03 2019	BUY Grant, award, or other acquisition	-	4,511 Added 11.11%	36,075 Common Stock
May 01 2019	SELL Payment of exercise price or tax liability	$181,830 $179.32 p/Share	1,014 Reduced 3.1%	31,738 Common Stock
Mar 22 2019	SELL Payment of exercise price or tax liability	$339,453 $191.89 p/Share	1,769 Reduced 5.12%	32,752 Common Stock
Mar 06 2019	BUY Grant, award, or other acquisition	-	3,676 Added 9.67%	34,324 Common Stock
Jan 30 2019	SELL Payment of exercise price or tax liability	$22,093 $192.11 p/Share	115 Reduced 0.37%	30,648 Common Stock
Nov 02 2018	BUY Grant, award, or other acquisition	-	12,830 Added 29.53%	30,618 Common Stock

DMR

David M Reese

EVP & Chief Technology Officer

Thousand Oaks,

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMGN shares.

Notify only if

Value

Insider Trading

Get notified when an Amgen Inc insider buys or sells AMGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMGEN INC

Track Activities on AMGN

Account